Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 09, 2018
Agilent Technologies has acquired Cork, Ireland-based Luxcel Biosciences, a developer of real-time fluorescence plate-reader based in vitro cell assay kits.
read more
Wednesday, March 21, 2018
MellingMedical was recently awarded a Federal Supply Schedule 65IB Drugs, Pharmaceuticals and Hematology Related Products.
read more
Catalent has invested a further $5 million at the company’s Somerset, New Jersey, drug development center of excellence to expand its OptiMelt® hot melt extrusion capabilities.
read more
Wednesday, April 10, 2019
ValGenesis has announced its release of VConnect, an automated data collection software module that enhances ValGenesis' VLMS ability to automatically capture test results.
read more
Paul Diolosa assumed the role of President and CEO of American Regent, Inc., a Daiichi Sankyo Group company, effective today.
read more
To mark its 10th anniversary, NuChem Sciences, Canada's largest contract research organization (CRO) in drug discovery chemistry, recently inaugurated its new laboratories located on Dobrin Street in Montreal.
read more
PAREXEL International Corporation, a global biopharmaceutical services provider, has announced the appointment of four company executives to its senior-most leadership team, the Business Review Committee.
read more
Thursday, December 01, 2022
Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian-expressed protein therapeutics, announced it has been granted a license to ATUM’s proprietary Leap-In Transposase...
read more
Thursday, January 25, 2024
Ichor Life Sciences, a full-service, end-to-end contract research organization (CRO) announced the expansion of Ichor Clinical’s services to Australia, Europe, and the United Kingdom.
read more
Monday, November 12, 2018
The FDA announced the U.S. Marshals Service has conducted a mass seizure of FDA-regulated products being held under insanitary conditions in which they were exposed to widespread rodent, insect and live animal infestation.
read more
Wednesday, February 13, 2019
Vizient announces it will create a centralized item master tool for a supply chain innovation program envisioned by the Captis network of member hospitals and providers.
read more
Pii announced the expansion of its commercial team with the additions of Wayne Ideus, Wayne Grellner and Ryan McFarlane.
read more
Wednesday, January 15, 2020
3D Systems and CollPlant Biotechnologies announced signing a joint development agreement intended to play a role in advancing and accelerating breakthroughs in the biomedical industry.
read more
Philogen S.p.A has entered into a Service and Supply Agreement with IBSA (Institut Biochimique SA) to produce a recombinant therapeutic protein at Philogen GMP Facilities in Siena (Italy).
read more
Monday, December 05, 2016
IT experts of TÜV Süd, a German industrial testing organization, have certified the new data processing center at Vetter's headquarters in Ravensburg, Germany. According to TÜV Süd, the pharmaceutical service provider has fulfilled all criteria ...
read more